wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47133172-3F87BB7F-0A4A-47BC-84E6-B53CF812EA96
Q47133172-3F87BB7F-0A4A-47BC-84E6-B53CF812EA96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47133172-3F87BB7F-0A4A-47BC-84E6-B53CF812EA96
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.
P2860
Q47133172-3F87BB7F-0A4A-47BC-84E6-B53CF812EA96
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47133172-3F87BB7F-0A4A-47BC-84E6-B53CF812EA96
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b2afd60e3c3e81b0e01fa96f42c35804de6c6c67
P2860
A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis